Citation Impact
Citing Papers
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
2003 StandoutScienceNobel
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
Plasmacytoid Dendritic Cell Dynamics and Alpha Interferon Production during Simian Immunodeficiency Virus Infection with a Nonpathogenic Outcome
2008 StandoutNobel
Evolution of new nonantibody proteins via iterative somatic hypermutation
2004 StandoutNobel
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
2008 StandoutNobel
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Origins of catalysis by computationally designed retroaldolase enzymes
2010 StandoutNobel
Progressive CD4+ central–memory T cell decline results in CD4+ effector–memory insufficiency and overt disease in chronic SIV infection
2007
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
A macaque model of HIV-1 infection
2009
MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness
1979 StandoutNobel
Human Immunodeficiency Virus, Restriction Factors, and Interferon
2009
Retroviral superinfection resistance
2005
Restricted expression of viral glycoprotein in cells of persistently infected mice
1982 Nature
Evolving epidemiology of hepatitis C virus
2010
APOBEC‐mediated interference with hepadnavirus production†
2005
Type I Interferons in Host Defense
2006
How Viruses Escape from Cytotoxic T Lymphocytes: Molecular Parameters and Players
1997
Factors Associated with the Emergence of K65R in Patients with HIV‐1 Infection Treated with Combination Antiretroviral Therapy Containing Tenofovir
2008
Duration of antiviral immunity after smallpox vaccination
2003 Standout
Initiation of Antiretroviral Therapy at CD4 Cell Counts ≥350 Cells/mm3 Does Not Increase Incidence or Risk of Peripheral Neuropathy, Anemia, or Renal Insufficiency
2008
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 × 106/l
2002
Antiretroviral Therapy for HIV Infection
1998
Interferon‐inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication†
2006
CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained
2000
DNA deamination in immunity
2005
Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis
2010
Natural controlled HIV infection: Preserved HIV-specific immunity despite undetectable replication competent virus
2005
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
2010 StandoutNobel
Intrinsic immunity: a front-line defense against viral attack
2004
Functional Impairment of CD8+ T Cells by Regulatory T Cells during Persistent Retroviral Infection
2004 StandoutNobel
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Treatment for Adult HIV Infection
2006
Host factors in the pathogenesis of HIV disease
1997
MX2 is an interferon-induced inhibitor of HIV-1 infection
2013 StandoutNatureNobel
Overcoming T cell exhaustion in infection and cancer
2015
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
2004
Retroviral restriction by APOBEC proteins
2004
Non‐redundancy of cytidine deaminases in class switch recombination
2004
Pharmacokinetics, Safety, and Efficacy of Tipranavir Boosted With Ritonavir Alone or in Combination With Other Boosted Protease Inhibitors as Part of Optimized Combination Antiretroviral Therapy in Highly Treatment-Experienced Patients (BI Study 1182.51)
2008
B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40
1993 StandoutNatureNobel
A 48-Week, Randomized, Open-Label Comparison of Three Abacavir-Based Substitution Approaches in the Management of Dyslipidemia and Peripheral Lipoatrophy
2003
Class I aldolases: Substrate specificity, mechanism, inhibitors and structural aspects
1995
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Immunopathogenesis and immunotherapy in AIDS virus infections
2003
Identification of a source of biologically active CD40 ligand
1992
Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel
2008
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
2006
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
2006 Standout
C-Terminal Deletion of AID Uncouples Class Switch Recombination from Somatic Hypermutation and Gene Conversion
2003
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
2005
Proline-catalysed Mannich reactions of acetaldehyde
2008 StandoutNatureNobel
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection
2003
The binding site for C1q on IgG
1988 StandoutNatureNobel
HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability
2003
Minority Quasispecies of Drug‐Resistant HIV‐1 That Lead to Early Therapy Failure in Treatment‐Naive and ‐Adherent Patients
2008
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Isolation and Immunophenotyping of Human and Rhesus Macaque Dendritic Cells
2004
Nonpathogenic SIV Infection of Sooty Mangabeys Is Characterized by Limited Bystander Immunopathology Despite Chronic High-Level Viremia
2003
Rates of evolutionary change in viruses: patterns and determinants
2008
Evaluation of antiretrovirals in animal models of HIV infection
2009
HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors
2002
Cytotoxic T lymphocytes in HIV-1 infection: a killing paradox?
1998
Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease
2007 StandoutNobel
Negative regulation of activation-induced cytidine deaminase in B cells
2006 StandoutNobel
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
1998 Standout
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
The mouse T cell receptor: Structural heterogeneity of molecules of normal T cells defined by Xenoantiserum
1983 StandoutNobel
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus
2004 StandoutNobel
Parallel Loss of Myeloid and Plasmacytoid Dendritic Cells from Blood and Lymphoid Tissue in Simian AIDS
2007
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation
2006
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes
2012 StandoutNobel
Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter.
1989 StandoutNobel
The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family
1985 StandoutNobel
APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection
2006 StandoutNobel
Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity
2005
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes
1998
Effects of in Vivo Cd8+ T Cell Depletion on Virus Replication in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine
1999
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.
1976
High Levels of Viral Replication during Primary Simian Immunodeficiency Virus SIVagm Infection Are Rapidly and Strongly Controlled in African Green Monkeys
2000 StandoutNobel
CRISPR-CasΦ from huge phages is a hypercompact genome editor
2020 StandoutScienceNobel
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
The C-terminal region of activation-induced cytidine deaminase is responsible for a recombination function other than DNA cleavage in class switch recombination
2009 StandoutNobel
Antiviral Potency of APOBEC Proteins Does Not Correlate with Cytidine Deamination
2006
Dendritic Cell-Specific Intercellular Adhesion Molecule 3-Grabbing Nonintegrin/CD209 Is Abundant on Macrophages in the Normal Human Lymph Node and Is Not Required for Dendritic Cell Stimulation of the Mixed Leukocyte Reaction
2005 StandoutNobel
Progenitor and Terminal Subsets of CD8 + T Cells Cooperate to Contain Chronic Viral Infection
2012 Science
Reward versus Risk: DNA Cytidine Deaminases Triggering Immunity and Disease
2005
Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutations
2006
Is Cytosolic Ionized Calcium Regulating Neutrophil Activation?
1983 StandoutScienceNobel
T-Independent Immune Response: New Aspects of B Cell Biology
2000 StandoutScienceNobel
Broad, Intense Anti-Human Immunodeficiency Virus (HIV) Ex Vivo CD8+Responses in HIV Type 1-Infected Patients: Comparison with Anti-Epstein-Barr Virus Responses and Changes during Antiretroviral Therapy
1999
Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti-Human Immunodeficiency Virus CD8+and CD4+T-Cell Responses from Chronically Infected Individuals
2001 StandoutNobel
In vitro granulocyte adherence and in vivo margination: two associated complement-dependent functions
1977
Characterization of the Alpha Interferon-Induced Postentry Block to HIV-1 Infection in Primary Human Macrophages and T Cells
2010
RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
2013 StandoutNobel
The Newick utilities: high-throughput phylogenetic tree processing in the Unix shell
2010
Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
1999
Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo
2005
Cytokine Expression, Natural Killer Cell Activation, and Phenotypic Changes in Lymphoid Cells from Rhesus Macaques during Acute Infection with Pathogenic Simian Immunodeficiency Virus
2000
Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1–infected subjects with progressive disease: changes after antiretroviral therapy
2003
HIV VACCINES
2005
The Biology and Detection of Immune Complexes
1980
Induction of Antiviral Cytidine Deaminases Does Not Explain the Inhibition of Hepatitis B Virus Replication by Interferons
2007
Reverse Transcriptase- and RNA Packaging Signal-Dependent Incorporation of APOBEC3G into Hepatitis B Virus Nucleocapsids
2008
Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt
2010
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Genome-wide somatic hypermutation
2004
Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response
2004
Normal T-Cell Turnover in Sooty Mangabeys Harboring Active Simian Immunodeficiency Virus Infection
2000
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1
2004 StandoutNobel
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
2000
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Trimmomatic: a flexible trimmer for Illumina sequence data
2014 Standout
De novo protein synthesis is required for activation-induced cytidine deaminase-dependent DNA cleavage in immunoglobulin class switch recombination
2004 StandoutNobel
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
2004
Works of Luc Perrin being referenced
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
2003 Nature
New complete genome sequences of human rhinoviruses shed light on their phylogeny and genomic features
2007
Nosocomial Outbreak of Multiple Bloodborne Viral Infections
2001
A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection
2002
Genetic polymorphism of CCR5 gene and HIV disease: The heterozygous (CCR5/Δccr5) genotype is neither essential nor sufficient for protection against disease progression
1997
Low Levels of Perforin Expression in CD8+T Lymphocyte Granules in Lymphoid Tissue during Acute Human Immunodeficiency Virus Type 1 Infection
2002
Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995
1998
A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection
1995
Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection
2002
Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20
2004
Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients
2005
Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection
2002
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA
2000
Travel and the spread of HIV-1 genetic variants
2003
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey
2007
Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy
2000
Quantitation of Human Immunodeficiency Virus Provirus and Circulating Virus: Relationship with Immunologic Parameters
1992
Expression, purification, biochemical characterization and inhibition of recombinant Plasmodium falciparum aldolase
1990
Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8–18 months of antiretroviral therapy in acutely infected patients
2001
Switch to Unusual Amino Acids at Codon 215 of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Gene in Seroconvertors Infected with Zidovudine-Resistant Variants
1998
Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes.
1976
Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system.
1975
The Formation and Fate of Virus Antigen-Antibody Complexes
1977
Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.
1976
HIV Treatment Failure: Testing for HIV Resistance in Clinical Practice
1998 Science
Improved detection of immune complexes in human and mouse serum using a microassay adaptation of the C1Q binding test
1979
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia
1997
Early and Prolonged Decrease of Viremia in HIV-1-Infected Patients Treated with Didanosine
1995
HIV-1 co/super-infection in intravenous drug users
2004
Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
1975
Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.
1976
Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes.
1977
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection
2002
Response of HIV RNA to didanosine as a predictive marker of survival
1995
Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody.
1979
Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS
2004
Immunologic Injury in Measles Virus Infection
1977
Limiting dilution assay for human B cells based on their activation by mutant EL4 thymoma cells: total and anti‐malaria responder B cell frequencies
1987
Measurement of Virus Antigens on the Surfaces of HeLa Cells Persistently Infected with Wild Type and Vaccine Strains of Measles Virus by Radioimmune Assay
1976
Analysis of HIV-1– and CMV-specific memory CD4 T-cell responses during primary and chronic infection
2002
Generation of virus-specific cytolytic activity in human peripheral lymphocytes after vaccination with vaccinia virus and measles virus
1978
EVIDENCE FOR IMMUNE-COMPLEX FORMATION IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS
1976
Infrequent Transmission of HIV-1 Drug-Resistant Variants
2004
Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
1975
Impact of Treatment with Human Immunodeficiency Virus (HIV) Protease Inhibitors on Hepatitis C Viremia in Patients Coinfected with HIV
1998
Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen
1998